Investors Denied Default $11.1M Award In Tibet Pharma Suit
A New Jersey federal judge on Friday declined to enter an $11.1 million default judgment against Tibet Pharmaceuticals Inc. for allegedly lying about its financial health before its 2011 initial public...To view the full article, register now.
Already a subscriber? Click here to view full article